Assignee
VIFOR INT AG
CH·14 granted patents·20 pending applications·148 citations·filing 1996–2024
Top patents by PatentIndex Score
34 records- 0193US7612109B2Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexesVIFOR INT AG·Filed 2003·Granted Nov 3, 2009·34 cites·27 claims
- 0293US6174442B1Adsorbent for phosphate from an aqueous medium, production and use of said adsorbentVIFOR INT AG·Filed 1996·Granted Jan 16, 2001·98 cites·14 claims
- 0391US10519252B2Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2013·Granted Dec 31, 2019·5 cites·26 claims
- 0490US10364239B2Ferroportin inhibitorsVIFOR INT AG·Filed 2016·Granted Jul 30, 2019·6 cites·21 claims
- 0587US11291645B2Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2020·Granted Apr 5, 2022·1 cites·21 claims
- 0687US11123321B2Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2020·Granted Sep 21, 2021·1 cites·29 claims
- 0785US2022387371A1Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2022·Application pending·0 cites
- 0881US2024336640A1Calcium oxalate crystallization inhibitors for renal disordersVIFOR INT AG·Filed 2024·Application pending·0 cites
- 0974US11590097B2Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2019·Granted Feb 28, 2023·0 cites·17 claims
- 1074US2010099647A1Aqueous Iron Carbohydrate Complexes, Their Production And Medicaments Containing ThemVIFOR INT AG·Filed 2009·Application pending·0 cites
- 1173US11129820B2Ferroportin-inhibitor saltsVIFOR INT AG·Filed 2018·Granted Sep 28, 2021·2 cites·26 claims
- 1273US2014371169A1Aqueous iron carbohydrate complexes, their production and medicaments containing themVIFOR INT AG·Filed 2014·Application pending·0 cites
- 1372US11066399B2Ferroportin inhibitorsVIFOR INT AG·Filed 2020·Granted Jul 20, 2021·0 cites·6 claims
- 1471US2022363675A1Novel Ferroportin InhibitorsVIFOR INT AG·Filed 2021·Application pending·0 cites
- 1568US11001579B2Ferroportin inhibitorsVIFOR INT AG·Filed 2019·Granted May 11, 2021·0 cites·11 claims
- 1664US9102688B2Sulfonaminoquinoline hepcidin antagonistsVIFOR INT AG·Filed 2014·Granted Aug 11, 2015·1 cites·16 claims
- 1761US2014335202A1Iron Sulfate-Based Phosphate AdsorbentVIFOR INT AG·Filed 2014·Application pending·0 cites
- 1856US2024100074A1Clinical Dosing Schedule of Inositol Phosphate Oligo(Ethylene Glycol) CompoundsVIFOR INT AG·Filed 2022·Application pending·0 cites
- 1956US2010294791A1Tablet DispenserVIFOR INT AG·Filed 2008·Application pending·0 cites
- 2055US2023212159A1Process for the Production of Ferroportin InhibitorsVIFOR INT AG·Filed 2021·Application pending·0 cites
- 2155US2024343722A1N-substituted ferroportin inhibitorsVIFOR INT AG·Filed 2022·Application pending·0 cites
- 2253US2024239780A1Modified ferroportin inhibitorsVIFOR INT AG·Filed 2022·Application pending·0 cites
- 2353US2025268878A1Ferroportin-inhibitors for the use in the treatment of myelodysplastic syndromes (mds)VIFOR INT AG·Filed 2022·Application pending·0 cites
- 2451US2008269167A1Preparation Comprising Iron(III) Complex Compounds And Redox-Active Substance(s)VIFOR INT AG·Filed 2006·Application pending·0 cites
- 2550US9248134B1Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemiasVIFOR INT AG·Filed 2014·Granted Feb 2, 2016·0 cites·15 claims
- 2648US2022323416A1Ferroportin-Inhibitors For The Use In The Prevention And Treatment Of Kidney InjuriesVIFOR INT AG·Filed 2020·Application pending·0 cites
- 2748US2013157974A1Preparation Comprising Iron(III) Complex Compounds And Redox-Active Substance(s)VIFOR INT AG·Filed 2013·Application pending·0 cites
- 2848US2009169645A1Iron Sulfate-Based Phosphate AdsorbentVIFOR INT AG·Filed 2005·Application pending·0 cites
- 2948US2022054540A1Ferric Carboxymaltose In The Treatment Of Heart Failure And In The Treatment Of Congestion In Heart FailureVIFOR INT AG·Filed 2019·Application pending·0 cites
- 3044US2022274973A1Methods And Compositions For Treating Sickle Cell Disease With A Ferroportin Inhibitor (VIT-2763)VIFOR INT AG·Filed 2020·Application pending·0 cites
- 3143US9943498B2Fe(III) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemiasVIFOR INT AG·Filed 2016·Granted Apr 17, 2018·0 cites·12 claims
- 3243US2008299285A1Process For The Preparation Of Ferri-SuccinylcaseinVIFOR INT AG·Filed 2006·Application pending·0 cites
- 3340US12533348B2Ferroportin-inhibitors for the use in the treatment of transfusion-dependent beta-thalassemia (TDT)VIFOR INT AG·Filed 2020·Granted Jan 27, 2026·0 cites·18 claims
- 3437US2008234226A1Use Of Iron(III) Complex Compounds For The Preparation Of A Medicament For Oral Treatment Of Iron Deficiency States In Patients With Chronic Inflammatory Bowel DiseaseVIFOR INT AG·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VIFOR INT AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →